HomeVERV • NASDAQ
add
Verve Therapeutics Inc
Previous close
$4.96
Day range
$4.96 - $5.10
Year range
$4.31 - $20.12
Market cap
422.28M USD
Avg Volume
1.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 6.69M | 219.73% |
Operating expense | 14.55M | 8.43% |
Net income | -49.80M | 7.74% |
Net profit margin | -744.25 | 71.14% |
Earnings per share | -0.59 | 32.18% |
EBITDA | -57.17M | 0.13% |
Effective tax rate | -0.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 575.95M | 24.54% |
Total assets | 700.91M | 18.97% |
Total liabilities | 154.82M | 24.94% |
Total equity | 546.09M | — |
Shares outstanding | 84.62M | — |
Price to book | 0.77 | — |
Return on assets | -20.53% | — |
Return on capital | -23.07% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -49.80M | 7.74% |
Cash from operations | -34.16M | 28.78% |
Cash from investing | 30.15M | -8.71% |
Cash from financing | 1.30M | 5.27% |
Net change in cash | -2.71M | 80.22% |
Free cash flow | -16.42M | 44.90% |
About
Founded
2018
Headquarters
Website
Employees
255
